
The BioPharm Brief: Fibrosis, Bispecific ADCs, and Billion-Dollar Deals
Published: | Updated:
Europe updates the guideline on excipients information in labeling and packaging.
On October 9, 2017, the European Medicines Agency (EMA) announced that the
The guideline was updated to take into consideration safety concerns not currently addressed in the existing annex, with specific attention to excipients that may affect children or pregnant women. Five new excipients are included, and 10 have been updated with new safety warnings.
Source:




